Artwork

Content provided by Alice Watson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alice Watson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S06 E03: Investigating the reality of rare disease research

28:12
 
Share
 

Manage episode 380070517 series 3299609
Content provided by Alice Watson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alice Watson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Discover the reality behind the expectations of rare disease research and drug development with Isabel and Jade as they present a discussion with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer. Tune in to hear Ian and Isabel discuss the current pharmaceutical landscape for rare diseases, including discussions around clinical trials, partnering early in the drug lifecycle, what the industry should be keeping in mind for the future of the field and much more. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
  continue reading

267 episodes

Artwork
iconShare
 
Manage episode 380070517 series 3299609
Content provided by Alice Watson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alice Watson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Discover the reality behind the expectations of rare disease research and drug development with Isabel and Jade as they present a discussion with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer. Tune in to hear Ian and Isabel discuss the current pharmaceutical landscape for rare diseases, including discussions around clinical trials, partnering early in the drug lifecycle, what the industry should be keeping in mind for the future of the field and much more. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
  continue reading

267 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide